60 In the index

Nefiracetam NEFI

A brain-supplement compound studied in Japan for helping cognitive problems after a stroke. Those studies showed some benefit, but it wasn't approved as widely as other stroke-recovery treatments and has little research outside that specific group of patients.

Also known as DM-9384, Nefiracetamum, 1JK12GX30N, RefChem:832135, Translon, DM 9384, Nefiracetam [INN], Motiva

Effects Focus Mood

Routes Oral

Legal status Research chemical

WADA Not listed

3D Molecular Structure of C₁₄H₁₈N₂O₂

Drag to rotate · scroll to zoom

Chemistry

Formula: C14H18N2O2
Molar mass: 246.30
CAS: 77191-36-7
PubChem CID: 71157
IUPAC name: N-(2,6-dimethylphenyl)-2-(2-oxopyrrolidin-1-yl)acetamide
InChIKey: NGHTXZCKLWZPGK-UHFFFAOYSA-N

Reported dosing

Clinical data

What has been reported in the literature and by users. This is a record of what is done, not a recommendation.

Typical dose 200-600 mg/day

Reported range 150-900 mg/day

Route Oral

Frequency 1-3 times daily

Duration Ongoing (supplement use)

Studied in Japan for post-stroke depression and cognitive impairment but never gained wide approval; sold in the West only as an unregulated nootropic supplement.

Where this comes from Japanese clinical trials; supplement-industry dosing

These figures are recorded for reference and are not a recommendation. Dosing is a decision for you and a clinician.